"There has been a protracted-standing want for additional effective treatments for treatment-resistant depression, a serious and existence-threatening ailment," reported Tiffany Farchione, M.D., performing director with the Division of Psychiatry Solutions in the FDA's Center for Drug Evaluation and Research. "Managed clinical trials that analyzed